- Investigator
- Michael R Bubb
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Actins , 37 publications
- Amino Acid Sequence , 18 publications
- Microfilament Proteins , 18 publications
- Protein Binding , 13 publications
Research activity
Active clinical trials
This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammatory Myopathy (IIM). Participants with the IIM subtypes of dermatomyositis (DM), immune-mediated…
- Investigator
- Michael R Bubb
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
This is a phase 3, multicenter, randomized, placebo-controlled, double-blind study of treatment with brepocitinib (TYK2/JAK1 inhibitor) in adults with dermatomyositis (DM). The primary objective of this study is to assess the efficacy of two dose…
- Investigator
- Michael R Bubb
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
My publications
Filter publications
78 publications
2022
A clinician's perspective on why the trial did not work: comment on the editorial by Merrill.
Arthritis & rheumatology (Hoboken, N.J.)
PubMed • Publisher's site2021
Egg Consumption and Cardiovascular Risk: Limitations of Observational Data.
The American journal of medicine
PubMed • Publisher's site2021
Subgingival microbiome of deep and shallow periodontal sites in patients with rheumatoid arthritis: a pilot study.
BMC oral health
PubMed • Publisher's site2020
Do Hydroxychloroquine Blood Levels and Dose Identify Different Populations at Risk of Retinopathy? Comment on the Article by Petri et al.
Arthritis & rheumatology (Hoboken, N.J.)
PubMed • Publisher's site2020
The Mismatch of Nutrition and Lifestyle Beliefs and Actions Among Physicians: A Wake-Up Call.
American journal of lifestyle medicine
PubMed • Publisher's site